Occurrence of Extended-Spectrum Beta-Lactamases Among Blood Culture Isolates of Gram-Negative Bacteria

Size: px
Start display at page:

Download "Occurrence of Extended-Spectrum Beta-Lactamases Among Blood Culture Isolates of Gram-Negative Bacteria"

Transcription

1 Original Article Vol. 21 No. 2 ESBL producers among blood culture isolates:- Kapoor L, Deb M. 53 Occurrence of Extended-Spectrum Beta-Lactamases Among Blood Culture Isolates of Gram-Negative Bacteria Lata Kapoor, M.D. Monorama Deb, M.D. ABSTRACT The purpose of this study was to determine the frequency of extended-spectrum betalactamases (ESBLs) in gram-negative bacteria isolated from blood cultures, and the susceptibility of these isolates to non-beta-lactam antibiotics. A total of 130 isolates from patients of all age groups were collected over a period of 4 months. ESBL-production was detected by Jarlier s double disc diffusion synergy test (DDST) and by a modified version of this test based on reduced inter-disc distance. ESBLproducing strains were examined for the susceptibility to amikacin, chloramphenicol, ciprofloxacin, gentamicin and netilmicin. Ten percent of gram-negative isolates showed ESBL production by the modified DDST, and no isolates could be detected by Jarlier s test. These isolates showed high susceptibility to ciprofloxacin (69%) and chloramphenicol (54%). Klebsiella pneumoniae was found to be the predominant ESBL producer. It was observed that the modified DDST is simple, practical and not technically demanding. It would be carried out in a busy clinical laboratory for the detection of ESBLs in our hospitals. (J Infect Dis Antimicrob Agents 2004;21:53-8.) INTRODUCTION In recent years, bacterial resistance to betalactam antibiotics has risen dramatically. In gramnegative bacteria, beta-lactamase production remains the most important contributing factor to beta-lactam resistance. 1 Extended-spectrum beta-lactamases (ESBLs) constitute a growing class of beta-lactamases that have been found in the Enterobacteriaceae and Pseudomonas aeruginosa. The classification scheme of beta-lactamases by Bush, Jacoby and Medeiros places ESBLs in the functional group 2be capable of hydrolyzing oxyimino-cephalosporins (cefotaxime, ceftazidime and ceftriaxone) and/or the monobactams (aztreonam). They are commonly inhibited by betalactamase inhibitors. 2 ESBLs are typically encoded on large kb plasmids which can be exchanged between bacterial species resulting in cross-transmission, thereby spreading resistance among related and unrelated gramnegative bacteria. These plasmids may encode other antimicrobial resistance genes. Therefore, bacteria expressing an ESBL may express co-resistance to Department of Microbiology, Lady Hardinge Medical College and Associated Hospitals, Delhi, India Received for publication: April 27, Reprint request: Dr Lata Kapoor, 128, Jailakshmi Apartments, 59, I.P. Extension, Delhi, India PIN latakapoor@yahoo.co.in Keywords: Extended-spectrum beta-lactamases, gram-negative bacteria, blood culture isolates 53

2 54 J INFECT DIS ANTIMICROB AGENTS May-Aug aminoglycosides, trimethoprim-sulfamethoxazole and tetracyclines and contribute to treatment failures, making it necessary to identify the prevalence of these strains in the hospitals. 3 The present study was undertaken to determine the frequency of ESBLs in gram-negative bacteria isolated from blood cultures and to examine the susceptibility of the ESBL-producing isolates to nonbeta-lactam antibiotics. MATERIALS AND METHODS This study included a total of 130 consecutive isolates of gram-negative bacteria recovered in pure culture from blood samples at the Department of Microbiology, Lady Hardinge Medical College and associated hospitals, Smt. Sucheta Kriplani Hospital (800 bedded) and Kalawati Saran Childrens Hospital (300 bedded). These are tertiary care hospitals situated in Delhi, India. The study period was for duration of 4 months from September to December The isolates were obtained from single blood culture specimen from patients of all age groups admitted to the intensive care units (ICUs), non-intensive care units (non-icus), nursery, neonatal unit (NNU), and from the out-patient department (OPD). Bacterial isolates 0.5 ml-2 ml (for neonates and children) and 5 ml (for adults) of blood were collected and inoculated into glucose broth in blood culture bottles in a ratio of 1:10. After overnight incubation at 37 C, subcultures were done on sheep blood agar and MacConkey agar [Hi- Media Laboratories, Mumbai, India]. Antimicrobial susceptibility of the isolates was determined by the Kirby Bauer disc diffusion method as described by the National Committee for Clinical Laboratory Standards (NCCLS). 4 The antimicrobial discs used included amikacin (30 g), ampicillin (10 g), amoxicillin+clavulanic acid (20 g+10 g), ceftazidime (30 g), cefotaxime (30 g), ceftriaxone (30 g), cefuroxime (30 g), chloramphenicol (30 g), ciprofloxacin (5 g), gentamicin (10 g) and netilmicin (30 g) [Hi-Media Laboratories, Mumbai, India]. Mueller-Hinton agar [Hi-Media Laboratories, Mumbai, India] plates were inoculated with the test inoculum adjusted to a turbidiy of 0.5 McFarland standard. Plates were incubated overnight at 37 C. Quality control was performed by testing Escherichia coli ATCC and Pseudomonas aeruginosa ATCC Susceptibility tests were interpreted by using the breakpoints as recommended by the NCCLS. 4 The minimal inhibitory concentration (MIC) of cefotaxime [Hi-Media Laboratories, Mumbai, India] for all the isolates was determined by the agar dilution method. 5 ESBL detection The ESBL-producing ability of all isolates was determined by Jarlier s double disc synergy test (DDST). In this test, the discs of expanded-spectrum cephalosporins (ESCs), namely cefotaxime and ceftazidime, and beta-lactamase inhibitor (amoxicillin+ clavulanic acid) were placed at a distance of 30 mm (center to center). A modified version of this test was also carried out with the distance between the discs reduced to 15 mm. 6,7 Two Mueller-Hinton plates were inoculated with standard inoculum (turbidity corresponding to 0.5 McFarland) for each test organism. Cefotaxime and ceftazidime discs were placed on two sides of an amoxicillin+clavulanic acid disc in the center of the plate. The center-to-center distance between the discs was 30 mm on one plate and at a distance of 15 mm on the other. (Figure 1) The plates were examined after an overnight incubation at 37 C. If the isolate was an ESBL producer, the zone of inhibition around the cefotaxime/ceftazidime disc was extended towards the amoxicillin+clavulanic acid disc. E. coli ATCC was used as a negative control and an in-house ESBLproducing strain was used as the positive control. RESULTS One hundred and thirty isolates were obtained from blood cultures of patients (Table 1). There were 102 pediatric patients and 28 adult patients (73

3 Vol. 21 No. 2 ESBL producers among blood culture isolates:- Kapoor L, Deb M. 55 Figure 1. DDST of a representative isolate of ESBL-producing Klebsiella pneumoniae. A: interdisc distance of 30 mm, B: interdisc distance of 15 mm, AC: amoxicillin+clavulanic acid, CE: cefotaxime, CA: ceftazidime. Table 1. Age wise distribution of patients (n=130). Age group Non ICU ICU NNU Nursery OPD Total (%) 0-1 months (49%) 1-12 months (5%) 1-5 yrs (15%) 5-10 yrs (8%) Adults (22%) Total 50 (39%) 16 (12%) 47 (36%) 5 (4%) 12 (9%) 130 ICU: Intensive care unit; NNU-Neonatal unit; OPD-Out-patient department males and 57 females). The gram-negative bacterial isolates included Klebsiella pneumoniae (55, 42%), E. coli (19, 15%), Acinetobacter spp. (16, 12%), Enterobacter aerogenes (14, 11%), Salmonella typhi (12, 9%), Salmonella paratyphi (8, 6%), and P. aeruginosa (6, 5%) (Table 2). S. paratyphi and S. typhi were obtained from outpatients, while the remaining isolates were isolated from cultures of hospitalized patients. All isolates belonging to the family Enterobacteriaceae except Salmonella spp. were resistant to ampicillin and amoxicillin+clavulanic acid (Table 2). Most isolates of Salmonella spp. were susceptible 55 to all antibiotics tested. Four isolates of S. typhi were resistant to ampicillin and chloramphenicol and of these, 2 were also resistant to amoxicillin+clavulanic acid. Four isolates of S. paratyphi A were resistant to cefuroxime. The MICs of cefotaxime for the resistant isolates ranged from 64 to > 1,024 g/ml whereas the MICs of control strains were < 0.5 g/ml for E. coli and 8 g/ml for P. aeruginosa (data not shown). Jarlier s DDST test did not detect ESBL production, while 13 isolates (10%) showed ESBL activity with the modified DDST test with reduced distance between discs. ESBL producers were

4 56 J INFECT DIS ANTIMICROB AGENTS May-Aug Table 2. Resistance pattern of the isolates to antimicrobials by disc diffusion method (n = 130). Total numbers Ampicillin Amikacin Amoxicillin+clavulanic acid Cefotaxime Ceftazidime Ceftriaxone Cefuroxime Chloramphenicol Organism Ciprofloxacin Gentamicin Netilmicin K. pneumoniae (100) 50 (91) 55 (100) 50 (91) 53 (96) 49 (89) 54 (98) 48 (87) 37 (67) 49 (89) 49 (89) S.typhi 12 4 (33) 0 2 (17) (33) S. paratyphi E. coli (100) 6 (32) 19 (100) 14 (74) 14 (74) 6 (43) 16 (84) 10 (53) 15 (79) 16 (84) 17 (89) Acinetobacter spp (50) 5 (31) 5 (31) 5 (31) 7 (44) 11 (69) 10 (62) 8 (50) 4 (25) 5 (31) 7 (44) E. aerogenes (100) 4 (29) 14 (100) 5 (36) 8 (57) 5 (36) 4 (29) 4 (29) 2 (14) 7 (50) 6 (43) P. aeruginosa 6 NT 2 (33) NT 3 (50) 4 (67) 4 (67) 4 (67) 3 (50) 1 (17) 3 (50) 4 (67) *Numbers in parentheses indicate percentage * NT: not tested

5 Vol. 21 No. 2 ESBL producers among blood culture isolates:- Kapoor L, Deb M. 57 Table 3. ESBL-producing isolates from various sources of the hospital (n=130). Isolates Non-ICUs ICUs NNU Nursery OPD Total K. pneumoniae 1/8 1/8 7/36 1/3-10/55 E. coli 2/12 0/3 0/ /19 Acinetobacter spp. 0/11 0/3-0/2-0/16 E. aerogenes 1/7 0/1 0/ /14 S. typhi 0/ /6 0/12 S. paratyphi 0/ /6 0/8 P. aeruginosa 0/4 0/1 0/ /6 Total 4/50 1/16 7/47 1/5 0/12 13/130 ICU: intensive care unit, NNU: neonatal unit, OPD: out-patient department Table 4. Susceptibility of ESBL-producers to non-beta-lactam antibiotics (%). Organism (No. of isolates producing ESBL) Amikacin Chloramphenicol Ciprofloxacin Gentamicin Netilmicin K. pneumoniae (10) E. coli (2) E. aerogenes (1) Total (13) 5 (38%) 7 (54%) 9 (69%) 4 (31%) 4 (31%) detected in isolates from ICUs (1), NNU (7) and non- ICUs (4) (Table 3). The susceptibility pattern of ESBL producers to non-beta-lactam antibiotics was as follows: 31% (4/13), 31% (4/31), 38% (5/13), 69% (9/13) and 54% (7/13) isolates were susceptible to netilmicin, gentamicin, amikacin, ciprofloxacin and chloramphenicol, respectively (Table 4). DISCUSSION Several studies have assessed the incidence of ESBLs in the Enterobacteriaceae. Most have focused primarily on E. coli and Klebsiella spp., of which the incidence of ESBLs is most common. 8,9,10,11 In our study, ESBL production was determined in the Enterobacteriaceae and other gram-negative bacteria isolated from blood cultures. The predominant gram-negative bacteria were K. pneumoniae followed by E. coli, Acinetobacter 57 spp., E. aerogenes, S. typhi, S. paratyphi and P. aeruginosa. This is similar to a study from Southern India, which reported Klebsiella spp. to be the predominant gram-negative bacteria isolated from bacteremic neonates followed by E. coli and Acinetobacter spp. 12 Another study from Northern India reported K. pneumoniae to be the most common isolate, but unlike the present study the next common isolate was found to be Salmonella spp. followed by Pseudomonas spp., Acinetobacter spp., E. coli and Enterobacter spp. 13 It is necessary to determine the prevalence of ESBL-producing isolates in a hospital to formulate the policy of empirical antibiotic therapy. This is important in the NNUs and the ICUs where a high percentage of infections are caused by resistant organisms. Although most isolates (69%) in the present study showed resistance to ESCs with high MIC values to cefotaxime

6 58 J INFECT DIS ANTIMICROB AGENTS May-Aug (64 - >1,024 g/ml), only 10 percent showed ESBL activity (14% of isolates resist to ESCs). Resistance to ESCs is explained by several mechanisms e.g. the expression of an Amp C-like beta-lactamase or expression of TEM-1 or SHV-1 beta-lactamase or associated alterations in the outer membrane permeability or the presence of a unique inhibitorresistant beta-lactamase. 14 ESBL-mediated resistance goes undetected unless specific tests for detection are used. 3,8,9 Among the 13 isolates producing ESBL in the present study, 3 (22%) were found to be susceptible to cefotaxime and ceftazidime on disc diffusion testing. Various laboratory tests are available for detection of ESBL activity. We used the DDST test and found the zone of enhancement only when the distance between the amoxicillin+clavulanic acid disc and ESC disc was reduced to 15-mm and not at 30-mm which was recommended by Jarlier. 7 This is similar to a report by Khurana et al who used various modifications of the DDST test and found that 15-mm distance gave the best results. 15 In the present study, ESBLs were detected in a total of 13 (10%) isolates, which included K. pneumoniae, E. coli and E. aerogenes. ESBL production could not be demonstrated in the other gram-negative bacteria, possibly due to the limited number of isolates. A study from the USA reported 9.3 percent of clinical isolates belonging to the Enterobacteriaceae to be ESBL producers. 16 A Belgian study reported a much higher prevalence of ESBLs (38.4%) among blood culture isolates of E. coli and K. pneumoniae. 9 A tertiary care hospital in India reported a 68-percent prevalence of ESBL producers among gram-negative bacterial isolates, though the number of organisms that were resistant to ESCs but did not show ESBL production have not been mentioned by them. 17 In the present study, only 14 percent of the isolates resistant to ESCs showed ESBL production and a study from Southern India reported 7 percent of resistant isolates were ESBL producing. 11 ESBL-producing K. pneumoniae strains were reported to be more prevalent than other ESBLproducing gram-negative bacteria. 15,17,18 In the present study, ESBL activity was demonstrated among 18 percent of K. pneumoniae followed by 10.5 percent of E. coli and 7 percent of E. aerogenes. Similar rates of ESBL-producing K. pneumoniae isolation (18%) was reported from West Indies. 19 A Russian study reported a prevalence of 61 percent ESBLproducing K. pneumoniae. 20 Villegas et al reported 33 percent of K. pneumoniae and 12 percent of E. coli to be ESBL producers. 21 Sixty-two percent of ESBL producers in our study were isolated from NNU and ICUs. In a study from France, most of ESBLproducing gram-negative isolates (31%) were recovered from the ICU. 6 In the present study, non-beta-lactam antibiotics with the greatest activity against the ESBL-producing isolates were ciprofloxacin (69%), followed by chloramphenicol (54%). This is similar to a study from Saudi Arabia, which reported ciprofloxacin (72%) had the greatest activity against ESBLproducers followed by amikacin (70%) and gentamicin (56%). 22 A report from India showed the highest susceptibility of ESBL-producers to amikacin (87%). 15 Currently, the NCCLS recommends an initial screening by testing for bacterial growth in a broth medium containing 1 g/ml of one of ESCs and further confirmed by determining the MICs of either cefotaxime or ceftazidime with and without clavulanic acid (4 g/ml). 2 These procedures are recommended only for E. coli, K. pneumoniae and K. oxytoca. The recommendations of NCCLS may not be feasible to perform in many routine clinical laboratories. The modified DDST is a simple, practical and low-cost test, which can be carried out in busy clinical laboratories. In conclusion, as the use of expanded-spectrum cephalosporins is becoming common in clinical practice and reported treatment failures are increasing, detection of ESBLs should be introduced in laboratories to

7 Vol. 21 No. 2 ESBL producers among blood culture isolates:- Kapoor L, Deb M. 59 assist clinical and infection control decisions. References 1. Bush K. New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin Infect Dis 2001;32: Bardford PA. Extended-spectrum beta-lactamases in the 21 st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001;14: Jacoby GA, Sutton L. Properties of plasmids responsible for production of extended-spectrum betalactamases. Antimicrob Agents Chemother 1991;35: National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. Approved standards M2- A7. Wayne (PA): National Committee for Clinical Laboratory Standards, Woods GL, Washington JA. Antibacterial susceptibility tests: dilution and disc diffusion methods. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology, 6 th ed. Washington DC: American Society of Microbiology, 1995: Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriacae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988;10: Ananthakrishnan AN, Kanungo R, Kumar A, Badrinath S. Detection of extended spectrum beta-lactamase producers among surgical wound infections and burns patients in JIPMER. Indian J Med Microbiol 2000;18: Jacoby GA, Han P. Detection of Extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol 1996;34: Vercauteren E, Descheemaeker P, Ieven M, Sanders CC, Goossens H. Comparison of screening methods for detection of extended-spectrum beta-lactamases 59 and their prevalence among blood culture isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital. J Clin Microbiol 1997;35: Hansotia JB, Vandana A, Pathak AA, Saoji AM. Extended spectrum beta-lactamase mediated resistance to third generation cephalosporins in Klebsiella pneumoniae in Nagpur, central India. Indian J Med Res 1997;105: Subha A, Ananthan S, Alavandi SV. Extended spectrum beta-lactamase production & multidrug resistance in Klebsiella species isolated from children under five with intestinal & extraintestinal infections. Indian J Med Res 2001;113: Thomas M, Padmini B, Srimathi G, Sundarajan V, Raju BA. Microbial profile of neonatal infection in Coimbatore. Indian J Pediatr 1999;66: Sharma M, Goel N, Chaudhary U, Aggarwal R, Arora DR. Bacteraemia in children. Indian J Pediatr 2002;69: Winokur PL, Canton R, Casellas JM, Legakis N. Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific Region. Clin Infect Dis 2001; 32 (Suppl 2):S Khurana S, Taneja N, Sharma M. Extended spectrum beta-lactamase mediated resistance in the urinary tract isolates of family Enterobacteriaceae. Indian J Med Res 2002;116: Coudron PE, Moland ES, Sanders CC. Occurrence and detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find. J Clin Microbiol 1997;35: Mathur P, Kapil A, Das B, Dhawan B. Prevalence of extended spectrum beta lactamase producing gramnegative bacteria in a tertiary care hospital. Indian J Med Res 2002;115: Revathi G. Detection of extended spectrum betalactamases using E test ESBL strip. Indian J Med Microbiol 1997;15: Nicholson AM, Gayle P, Roye-Green K. Extended-

8 60 J INFECT DIS ANTIMICROB AGENTS May-Aug spectrum beta-lactamase producing organisms at the University Hospital of West Indies. West Indian Med J 2004;53: Edelstein M, Pimkin M, Palagin I, Edelstein I, Stratchounski L. Prevalence and molecular epidemiology of CTX-M extended-spectrum betalactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob Agents Chemother 2003;47: Villegas MV, Correa A, Perez F, Miranda MC, Zuluaga T, Quinn JP. Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals. Diagn Microbiol Infect Dis 2004;49: Kader AA, Kumar AK. Prevalence of extended spectrum β-lactamase among multidrug resistant gram-negative isolates from a general hospital in Saudi Arabia. Saudi Med J 2004;25:570-4.

APPENDIX III - DOUBLE DISK TEST FOR ESBL

APPENDIX III - DOUBLE DISK TEST FOR ESBL Policy # MI\ANTI\04\03\v03 Page 1 of 5 Section: Antimicrobial Susceptibility Testing Manual Subject Title: Appendix III - Double Disk Test for ESBL Issued by: LABORATORY MANAGER Original Date: January

More information

Mili Rani Saha and Sanya Tahmina Jhora. Department of Microbiology, Sir Salimullah Medical College, Mitford, Dhaka, Bangladesh

Mili Rani Saha and Sanya Tahmina Jhora. Department of Microbiology, Sir Salimullah Medical College, Mitford, Dhaka, Bangladesh Detection of extended spectrum beta-lactamase producing Gram-negative organisms: hospital prevalence and comparison of double disc synergy and E-test methods Mili Rani Saha and Sanya Tahmina Jhora Original

More information

Prevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre

Prevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 4 Number 9 (2015) pp. 952-956 http://www.ijcmas.com Original Research Article Prevalence of Metallo-Beta-Lactamase

More information

Original Article. Suthan Srisangkaew, M.D. Malai Vorachit, D.Sc.

Original Article. Suthan Srisangkaew, M.D. Malai Vorachit, D.Sc. Original Article Vol. 21 No.1 The optimum agent for ESBL screening and confirmatory tests:- Srisangkaew S & Vorachit M. 1 The Optimum Agent for Screening and Confirmatory Tests for Extended-Spectrum Beta-Lactamases

More information

Prevalence of Extended Spectrum Beta- Lactamase Producers among Various Clinical Samples in a Tertiary Care Hospital: Kurnool District, India

Prevalence of Extended Spectrum Beta- Lactamase Producers among Various Clinical Samples in a Tertiary Care Hospital: Kurnool District, India International Journal of Current Microbiology and Applied Sciences ISSN: 319-77 Volume Number (17) pp. 57-3 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/1.5/ijcmas.17..31

More information

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat Hicham Ezzat Professor of Microbiology and Immunology Cairo University Introduction 1 Since the 1980s there have been dramatic

More information

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING CHN61: EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING 1.1 Introduction A common mechanism of bacterial resistance to beta-lactam antibiotics is the production

More information

Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory

Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory METHODS USED IN NEW ZEALAND DIAGNOSTIC LABORATORIES TO IDENTIFY AND REPORT EXTENDED-SPECTRUM β-lactamase- PRODUCING ENTEROBACTERIACEAE by Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory

More information

Detection of Inducible AmpC β-lactamase-producing Gram-Negative Bacteria in a Teaching Tertiary Care Hospital in North India

Detection of Inducible AmpC β-lactamase-producing Gram-Negative Bacteria in a Teaching Tertiary Care Hospital in North India Original Article Vol. 25 No. 3 Ampc β-lactamase Production in Gram-Negative Bacilli:-Chaudhary U, et al. 129 Detection of Inducible AmpC β-lactamase-producing Gram-Negative Bacteria in a Teaching Tertiary

More information

International Journal of Pharma and Bio Sciences ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF ESBL PRODUCING GRAM NEGATIVE BACILLI ABSTRACT

International Journal of Pharma and Bio Sciences ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF ESBL PRODUCING GRAM NEGATIVE BACILLI ABSTRACT Research Article Microbiology International Journal of Pharma and Bio Sciences ISSN 0975-6299 ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF ESBL PRODUCING GRAM NEGATIVE BACILLI * PRABHAKAR C MAILAPUR, DEEPA

More information

Detection of ESBL Producing Gram Negative Uropathogens and their Antibiotic Resistance Pattern from a Tertiary Care Centre, Bengaluru, India

Detection of ESBL Producing Gram Negative Uropathogens and their Antibiotic Resistance Pattern from a Tertiary Care Centre, Bengaluru, India ISSN: 2319-7706 Volume 4 Number 12 (2015) pp. 578-583 http://www.ijcmas.com Original Research Article Detection of ESBL Producing Gram Negative Uropathogens and their Antibiotic Resistance Pattern from

More information

European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The

More information

Version 1.01 (01/10/2016)

Version 1.01 (01/10/2016) CHN58: ANTIMICROBIAL SUSCEPTIBILITY TESTING (CLSI) 1.0 PURPOSE / INTRODUCTION: 1.1 Introduction Antimicrobial susceptibility tests are performed in order to determine whether a pathogen is likely to be

More information

Study of drug resistance pattern of principal ESBL producing urinary isolates in an urban hospital setting in Eastern India

Study of drug resistance pattern of principal ESBL producing urinary isolates in an urban hospital setting in Eastern India Research article Study of drug resistance pattern of principal ESBL producing urinary isolates in an urban hospital setting in Eastern India Mitali Chatterjee, 1 M. Banerjee, 1 S. Guha, 2 A.Lahiri, 3 K.Karak

More information

Original Article. Ratri Hortiwakul, M.Sc.*, Pantip Chayakul, M.D.*, Natnicha Ingviya, B.Sc.**

Original Article. Ratri Hortiwakul, M.Sc.*, Pantip Chayakul, M.D.*, Natnicha Ingviya, B.Sc.** Original Article In Vitro Activity of Cefminox and Other β-lactam Antibiotics Against Clinical Isolates of Extended- Spectrum-β-lactamase-Producing Klebsiella pneumoniae and Escherichia coli Ratri Hortiwakul,

More information

JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH

JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH How to cite this article: SHOBHA K L, RAMACHANDRA L, RAO G, MAJUMDER S, RAO S P. EXTENDED SPECTRUM BETA-LACTAMASES (ESBL) IN GRAM NEGATIVE BACILLI AT A TERTIARY

More information

AJMS Al Ameen J Med Sci (2 010 )3 (4 ): (An US National Library of Medicine enlisted journal) I S S N

AJMS Al Ameen J Med Sci (2 010 )3 (4 ): (An US National Library of Medicine enlisted journal) I S S N AJMS Al Ameen J Med Sci (2 010 )3 (4 ):2 6 5-2 7 1 (An US National Library of Medicine enlisted journal) I S S N 0 9 7 4-1 1 4 3 ORIGI NAL ARTICLE Frequency and Antimicrobial Sensitivity Pattern Of Extended

More information

Available Online at International Journal of Pharmaceutical & Biological Archives 2011; 2(5): ORIGINAL RESEARCH ARTICLE

Available Online at  International Journal of Pharmaceutical & Biological Archives 2011; 2(5): ORIGINAL RESEARCH ARTICLE ISSN 0976 3333 Available Online at www.ijpba.info International Journal of Pharmaceutical & Biological Archives 2011; 2(5):1502-1508 ORIGINAL RESEARCH ARTICLE Screening of ESBL (Extended Spectrum of β

More information

Extended-spectrum β-lactamases (ESBL) are enzymes produced

Extended-spectrum β-lactamases (ESBL) are enzymes produced DOI 10. 5001/omj.2013.30 Prevalence of Extended-spectrum β-lactamases-producing Escherichia coli from Hospitals in Khartoum State, Sudan Mutasim E. Ibrahim, Naser E. Bilal, Magzoub A. Magzoub, Mohamed

More information

European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01

More information

Prevalence of Extended-spectrum β-lactamase Producing Enterobacteriaceae Strains in Latvia

Prevalence of Extended-spectrum β-lactamase Producing Enterobacteriaceae Strains in Latvia Prevalence of Extended-spectrum β-lactamase Producing Enterobacteriaceae Strains in Latvia Ruta Paberza 1, Solvita Selderiņa 1, Sandra Leja 1, Jelena Storoženko 1, Lilija Lužbinska 1, Aija Žileviča 2*

More information

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

Routine internal quality control as recommended by EUCAST Version 3.1, valid from Routine internal quality control as recommended by EUCAST Version.1, valid from 01-01-01 Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus

More information

ALARMING RATES OF PREVALENCE OF ESBL PRODUCING E. COLI IN URINARY TRACT INFECTION CASES IN A TERTIARY CARE NEUROSPECIALITY HOSPITAL

ALARMING RATES OF PREVALENCE OF ESBL PRODUCING E. COLI IN URINARY TRACT INFECTION CASES IN A TERTIARY CARE NEUROSPECIALITY HOSPITAL ALARMING RATES OF PREVALENCE OF ESBL PRODUCING E. COLI IN URINARY TRACT INFECTION CASES IN A TERTIARY CARE NEUROSPECIALITY HOSPITAL Pearl. A Prabal*,Sourav Maiti Institute of Neurosciences, Kolkata, India

More information

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to

More information

Detection of extended-spectrum -lactamases in clinical isolates of E. coli and klebsiella species from Udaipur Rajasthan

Detection of extended-spectrum -lactamases in clinical isolates of E. coli and klebsiella species from Udaipur Rajasthan Biomedical Research 2011; 22 (3): 367-373 Detection of extended-spectrum -lactamases in clinical isolates of E. coli and klebsiella species from Udaipur Rajasthan Sushil Kumar Sahu, A. S. Dalal, G. Bansal

More information

Phenotypic Detection and Occurrence of Extended-Spectrum Beta-Lactamases in Clinical Isolates of Klebsiella pneumoniae and Escherichia coli

Phenotypic Detection and Occurrence of Extended-Spectrum Beta-Lactamases in Clinical Isolates of Klebsiella pneumoniae and Escherichia coli 516 BJID 2008; 12 (December) Phenotypic Detection and Occurrence of Extended-Spectrum Beta-Lactamases in Clinical Isolates of Klebsiella pneumoniae and Escherichia coli at a Tertiary Hospital in Trinidad

More information

Intrinsic, implied and default resistance

Intrinsic, implied and default resistance Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been

More information

ESBL & AmpC detection in Klebsiella species by Non Molecular methods

ESBL & AmpC detection in Klebsiella species by Non Molecular methods ISSN: 2319-7706 Volume 3 Number 4 (2014) pp. 323-329 http://www.ijcmas.com Original Research Article ESBL & AmpC detection in Klebsiella species by Non Molecular methods B.L.Chaudhary*, Nitin Goel Insan,

More information

COMPARISON OF DIFFERENT PHENOTYPIC METHODS FOR THE DETECTION OF EXTENDED SPECTRUM b- LACTAMASE (ESBL) IN BACTERIAL ISOLATES FROM TERTIARY CARE CENTRE

COMPARISON OF DIFFERENT PHENOTYPIC METHODS FOR THE DETECTION OF EXTENDED SPECTRUM b- LACTAMASE (ESBL) IN BACTERIAL ISOLATES FROM TERTIARY CARE CENTRE IJCRR Section: Healthcare Sci. Journal Impact Factor 4.016 Research Article COMPARISON OF DIFFERENT PHENOTYPIC METHODS FOR THE DETECTION OF EXTENDED SPECTRUM b- LACTAMASE (ESBL) IN BACTERIAL ISOLATES FROM

More information

Prevalence of extended-spectrum â-lactamaseproducing Gram-negative bacteria in septicaemic neonates in a tertiary care hospital

Prevalence of extended-spectrum â-lactamaseproducing Gram-negative bacteria in septicaemic neonates in a tertiary care hospital Journal of Medical Microbiology (2003), 52, 421 425 DOI 10.1099/jmm.0.04966-0 Prevalence of extended-spectrum â-lactamaseproducing Gram-negative bacteria in septicaemic neonates in a tertiary care hospital

More information

Prevalence and antibiogram of extended spectrum β- lactamase producing Klebsiella pneumoniae in a tertiary care hospita

Prevalence and antibiogram of extended spectrum β- lactamase producing Klebsiella pneumoniae in a tertiary care hospita 2014; 3 (2): 155-159 Available online at: www.jsirjournal.com Research Article ISSN 2320-4818 JSIR 2014; 3(2): 155-159 2014, All rights reserved Received: 18-02-2014 Accepted: 26-04-2014 Dr. Priyadarshini

More information

International Journal of Health Sciences and Research ISSN:

International Journal of Health Sciences and Research  ISSN: International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Antibiotic Susceptibility Pattern of Pseudomonas Aeruginosa Isolated From Various Clinical

More information

January 2014 Vol. 34 No. 1

January 2014 Vol. 34 No. 1 January 2014 Vol. 34 No. 1. and Minimal Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) roth dilution: cation-adjusted Mueller-Hinton

More information

ESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL

ESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL ESBL- and carbapenemase-producing microorganisms; state of the art Laurent POIREL Medical and Molecular Microbiology Unit Dept of Medicine University of Fribourg Switzerland INSERM U914 «Emerging Resistance

More information

Introduction Extended spectrum beta-lactamase (ESBL)-producing bacilli. Methods. KPP Abhilash 1, Balaji Veeraraghavan 2, OC Abraham 1.

Introduction Extended spectrum beta-lactamase (ESBL)-producing bacilli. Methods. KPP Abhilash 1, Balaji Veeraraghavan 2, OC Abraham 1. SUPPLEMENT TO JAPI december 2010 VOL. 58 13 Epidemiology and Outcome of Bacteremia Caused by Extended Spectrum Beta-Lactamase (Esbl)-producing Escherichia Coli and Klebsiella Spp. in a Tertiary Care Teaching

More information

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine 2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose

More information

Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria

Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria Juhee Ahn Department of Medical Biomaterials Engineering Kangwon National University October 23, 27 Antibiotic Development

More information

RETROSPECTIVE STUDY OF GRAM NEGATIVE BACILLI ISOLATES AMONG DIFFERENT CLINICAL SAMPLES FROM A DIAGNOSTIC CENTER OF KANPUR

RETROSPECTIVE STUDY OF GRAM NEGATIVE BACILLI ISOLATES AMONG DIFFERENT CLINICAL SAMPLES FROM A DIAGNOSTIC CENTER OF KANPUR Original article RETROSPECTIVE STUDY OF GRAM NEGATIVE BACILLI ISOLATES AMONG DIFFERENT CLINICAL SAMPLES FROM A DIAGNOSTIC CENTER OF KANPUR R.Sujatha 1,Nidhi Pal 2, Deepak S 3 1. Professor & Head, Department

More information

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals J Vet Diagn Invest :164 168 (1998) Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals Susannah K. Hubert, Phouc Dinh Nguyen, Robert D. Walker Abstract.

More information

2015 Antimicrobial Susceptibility Report

2015 Antimicrobial Susceptibility Report Gram negative Sepsis Outcome Programme (GNSOP) 2015 Antimicrobial Susceptibility Report Prepared by A/Professor Thomas Gottlieb Concord Hospital Sydney Jan Bell The University of Adelaide Adelaide On behalf

More information

EUCAST recommended strains for internal quality control

EUCAST recommended strains for internal quality control EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC

More information

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2. AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony

More information

Mechanism of antibiotic resistance

Mechanism of antibiotic resistance Mechanism of antibiotic resistance Dr.Siriwoot Sookkhee Ph.D (Biopharmaceutics) Department of Microbiology Faculty of Medicine, Chiang Mai University Antibiotic resistance Cross-resistance : resistance

More information

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory

More information

Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching Hospital, Bengaluru, India

Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching Hospital, Bengaluru, India ISSN: 2319-7706 Volume 4 Number 11 (2015) pp. 731-736 http://www.ijcmas.com Original Research Article Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching

More information

JMSCR Vol. 03 Issue 08 Page August 2015

JMSCR Vol. 03 Issue 08 Page August 2015 www.jmscr.igmpublication.org Impact Factor 3.79 ISSN (e)-2347-176x DOI: http://dx.doi.org/10.18535/jmscr/v3i8.07 Isolation of Extended Spectrum Β-Lactamases in Urine Samples Authors Sukesh Kumar B Y 1,

More information

Antimicrobial Susceptibility Testing: The Basics

Antimicrobial Susceptibility Testing: The Basics Antimicrobial Susceptibility Testing: The Basics Susan E. Sharp, Ph.D., DABMM, FAAM Director, Airport Way Regional Laboratory Director, Regional Microbiology and Molecular Infectious Diseases Laboratories

More information

Defining Extended Spectrum b-lactamases: Implications of Minimum Inhibitory Concentration- Based Screening Versus Clavulanate Confirmation Testing

Defining Extended Spectrum b-lactamases: Implications of Minimum Inhibitory Concentration- Based Screening Versus Clavulanate Confirmation Testing Infect Dis Ther (2015) 4:513 518 DOI 10.1007/s40121-015-0094-6 BRIEF REPORT Defining Extended Spectrum b-lactamases: Implications of Minimum Inhibitory Concentration- Based Screening Versus Clavulanate

More information

Antimicrobial susceptibility of Salmonella, 2016

Antimicrobial susceptibility of Salmonella, 2016 susceptibility of Salmonella, 06 Hospital and community laboratories are requested to refer all Salmonella isolated from human salmonellosis cases to ESR for serotyping and the laboratory-based surveillance

More information

PROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains

PROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains PROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains 1 INTRODUCTION... 1 2 OBJECTIVES... 2 3 OUTLINE OF THE EQAS 2017... 2 3.1 Shipping, receipt and storage of strains...

More information

THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS

THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS Stefanie Desmet University Hospitals Leuven Laboratory medicine microbiology stefanie.desmet@uzleuven.be

More information

International Journal of Pharma and Bio Sciences

International Journal of Pharma and Bio Sciences Research Article Microbiology International Journal of Pharma and Bio Sciences ISSN 0975-6299 PREVALENCE OF EXTENDED SPECTRUM BETA LACTAMASES AMONG GRAM NEGATIVE CLINICAL ISOLATES FROM A TERTIARY CARE

More information

Comparison of Susceptibility of Gram Negative Bacilli to Cephalosporins and Ciprofloxacin

Comparison of Susceptibility of Gram Negative Bacilli to Cephalosporins and Ciprofloxacin International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 5 Number 9 (2016) pp. 205-212 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2016.509.023

More information

Available online at ISSN No:

Available online at  ISSN No: Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2017, 6(4): 36-42 Comparative Evaluation of In-Vitro Doripenem Susceptibility with Other

More information

A retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya

A retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya A retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya LU Edirisinghe 1, D Vidanagama 2 1 Senior Registrar in Medicine, 2 Consultant Microbiologist,

More information

Int.J.Curr.Microbiol.App.Sci (2017) 6(3):

Int.J.Curr.Microbiol.App.Sci (2017) 6(3): International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 3 (2017) pp. 891-895 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.603.104

More information

Prevalence of Extended spectrum beta lactamase (ESBL) producing Pseudomonas aeruginosa strains recovered from human patients in Himachal Pradesh

Prevalence of Extended spectrum beta lactamase (ESBL) producing Pseudomonas aeruginosa strains recovered from human patients in Himachal Pradesh Original article: Prevalence of Extended spectrum beta lactamase (ESBL) producing Pseudomonas aeruginosa strains recovered from human patients in Himachal Pradesh Bharti and P.C.Sharma* Dept. of Microbiology,

More information

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards Janet A. Hindler, MCLS, MT(ASCP) UCLA Health System Los Angeles, California, USA jhindler@ucla.edu 1 Learning Objectives Describe information

More information

PILOT STUDY OF THE ANTIMICROBIAL SUSCEPTIBILITY OF SHIGELLA IN NEW ZEALAND IN 1996

PILOT STUDY OF THE ANTIMICROBIAL SUSCEPTIBILITY OF SHIGELLA IN NEW ZEALAND IN 1996 PILOT STUDY OF THE ANTIMICROBIAL SUSCEPTIBILITY OF SHIGELLA IN NEW ZEALAND IN 996 November 996 by Maggie Brett Antibiotic Reference Laboratory ESR Communicable Disease Centre Porirua CONTENTS Page SUMMARY

More information

Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC

Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC 11/20/2014 1 To describe carbapenem-resistant Enterobacteriaceae. To identify laboratory detection standards for carbapenem-resistant

More information

Antimicrobial Susceptibility Profile of E. coli Isolates Causing Urosepsis: Single Centre Experience

Antimicrobial Susceptibility Profile of E. coli Isolates Causing Urosepsis: Single Centre Experience International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 05 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.705.298

More information

Antibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); August 2017

Antibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); August 2017 Antimicrobial susceptibility of Shigella, 2015 and 2016 Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); August 2017

More information

Antimicrobial Susceptibility Patterns of Salmonella Typhi From Kigali,

Antimicrobial Susceptibility Patterns of Salmonella Typhi From Kigali, In the name of God Shiraz E-Medical Journal Vol. 11, No. 3, July 2010 http://semj.sums.ac.ir/vol11/jul2010/88030.htm Antimicrobial Susceptibility Patterns of Salmonella Typhi From Kigali, Rwanda. Ashok

More information

What s new in EUCAST methods?

What s new in EUCAST methods? What s new in EUCAST methods? Derek Brown EUCAST Scientific Secretary Interactive question 1 MIC determination MH-F broth for broth microdilution testing of fastidious microorganisms Gradient MIC tests

More information

Received: February 29, 2008 Revised: July 22, 2008 Accepted: August 4, 2008

Received: February 29, 2008 Revised: July 22, 2008 Accepted: August 4, 2008 J Microbiol Immunol Infect. 29;42:317-323 In vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections at a medical center

More information

Saudi Journal of Pathology and Microbiology (SJPM)

Saudi Journal of Pathology and Microbiology (SJPM) Saudi Journal of Pathology and Microbiology (SJPM) Scholars Middle East Publishers Dubai, United Arab Emirates Website: http://scholarsmepub.com/ ISSN 2518-3362 (Print) ISSN 2518-3370 (Online) A Prevalence

More information

Michael Hombach*, Guido V. Bloemberg and Erik C. Böttger

Michael Hombach*, Guido V. Bloemberg and Erik C. Böttger J Antimicrob Chemother 2012; 67: 622 632 doi:10.1093/jac/dkr524 Advance Access publication 13 December 2011 Effects of clinical breakpoint changes in CLSI guidelines 2010/2011 and EUCAST guidelines 2011

More information

Aerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune

Aerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune Original article Aerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune Patil P, Joshi S, Bharadwaj R. Department of Microbiology, B.J. Medical College, Pune, India. Corresponding

More information

Infectious Diseases: Research and Treatment 2014:7

Infectious Diseases: Research and Treatment 2014:7 Open Access: Full open access to this and thousands of other papers at http://www.la-press.com. Infectious Diseases: Research and Treatment Antimicrobial Susceptibility Profile of Extended Spectrum β-lactamase

More information

Antimicrobial susceptibility of Salmonella, 2015

Antimicrobial susceptibility of Salmonella, 2015 Antimicrobial susceptibility of Salmonella, 2015 Hospital and community laboratories are requested to refer all Salmonella isolated from human salmonellosis cases to ESR for serotyping and the laboratory-based

More information

Antimicrobial Susceptibility Testing: Advanced Course

Antimicrobial Susceptibility Testing: Advanced Course Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to

More information

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical

More information

Detection of ESBL Production Among Hospital AndCommunity Isolates of Klebsiellapneumoniae

Detection of ESBL Production Among Hospital AndCommunity Isolates of Klebsiellapneumoniae IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 5 Ver. VI (May. 2016), PP 40-46 www.iosrjournals.org Detection of ESBL Production Among Hospital

More information

Evaluation of a new cefepime clavulanate ESBL Etest to detect extended-spectrum b-lactamases in an Enterobacteriaceae strain collection

Evaluation of a new cefepime clavulanate ESBL Etest to detect extended-spectrum b-lactamases in an Enterobacteriaceae strain collection Journal of Antimicrobial Chemotherapy (2004) 54, 134 138 DOI: 10.1093/jac/dkh274 Advance Access publication 18 May 2004 Evaluation of a new cefepime clavulanate ESBL Etest to detect extended-spectrum b-lactamases

More information

JOURNAL OF INTERNATIONAL ACADEMIC RESEARCH FOR MULTIDISCIPLINARY Impact Factor 1.625, ISSN: , Volume 3, Issue 4, May 2015

JOURNAL OF INTERNATIONAL ACADEMIC RESEARCH FOR MULTIDISCIPLINARY Impact Factor 1.625, ISSN: , Volume 3, Issue 4, May 2015 PHENOTYPIC DETECTION OF FAECAL CARRIAGE EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE IN HILLA CITY Dr. FATIMA MOEEN ABBAS* *Dept. of Biology, College of Sciences for Women, University

More information

1 INTRODUCTION OBJECTIVES OUTLINE OF THE SALM/CAMP EQAS

1 INTRODUCTION OBJECTIVES OUTLINE OF THE SALM/CAMP EQAS PROTOCOL For antimicrobial susceptibility testing of Salmonella, Campylobacter and optional genotypic characterisation of AmpC-, ESBL- and carbapenemase-producing test strains 1 INTRODUCTION... 1 2 OBJECTIVES...

More information

GENERAL NOTES: 2016 site of infection type of organism location of the patient

GENERAL NOTES: 2016 site of infection type of organism location of the patient GENERAL NOTES: This is a summary of the antibiotic sensitivity profile of clinical isolates recovered at AIIMS Bhopal Hospital during the year 2016. However, for organisms in which < 30 isolates were recovered

More information

Cephalosporins Susceptibility Test in Urinary Tract Infection

Cephalosporins Susceptibility Test in Urinary Tract Infection CEPHALOSPORINS THE IRAQI POSTGRADUATE SUSCEPTIBILITY MEDICAL JOURNAL TEST IN URINARY TRACT INFECTION VOL.9, NO.3, 2010 Cephalosporins Susceptibility Test in Urinary Tract Infection Mithaq Sabeeh Al-Nassiry*,

More information

CONTAGIOUS COMMENTS Department of Epidemiology

CONTAGIOUS COMMENTS Department of Epidemiology VOLUME XXIII NUMBER 1 July 2008 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell, SM (ASCP), Marti Roe SM (ASCP), Ann-Christine Nyquist MD, MSPH Are the bugs winning? The 2007

More information

Performance Information. Vet use only

Performance Information. Vet use only Performance Information Vet use only Performance of plates read manually was measured in three sites. Each centre tested Enterobacteriaceae, streptococci, staphylococci and pseudomonas-like organisms.

More information

CO EXPRESSION OF BETALACTAMASES IN GRAM NEGATIVE BACILLI ISOLATED FROM CLINICAL SAMPLES

CO EXPRESSION OF BETALACTAMASES IN GRAM NEGATIVE BACILLI ISOLATED FROM CLINICAL SAMPLES Original Research Article DOI: 10.26479/2018.0403.38 CO EXPRESSION OF BETALACTAMASES IN GRAM NEGATIVE BACILLI ISOLATED FROM CLINICAL SAMPLES Sai leela kondapaneni Department of Microbiology, Katuri Medical

More information

Irrational use of antimicrobial agents often

Irrational use of antimicrobial agents often Antibiotic Resistance of Isolated Bacteria in 1 and Abdo-Rabbo A. 2 Irrational use of antimicrobial agents often leads to the multi-drug resistance microorganisms. This study is aimed at investigating

More information

EUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM)

EUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM) EUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM) Christian G. Giske, MD/PhD Chairman of ESDReM Karolinska University Hospital and EUCAST ECCMID, 22 maj 2013 The background Guidance on

More information

Antimicrobial Cycling. Donald E Low University of Toronto

Antimicrobial Cycling. Donald E Low University of Toronto Antimicrobial Cycling Donald E Low University of Toronto Bad Bugs, No Drugs 1 The Antimicrobial Availability Task Force of the IDSA 1 identified as particularly problematic pathogens A. baumannii and

More information

BACTERIOLOGICAL PROFILE AND ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF ISOLATES OF NEONATAL SEPTICEMIA IN A TERTIARY CARE HOSPITAL

BACTERIOLOGICAL PROFILE AND ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF ISOLATES OF NEONATAL SEPTICEMIA IN A TERTIARY CARE HOSPITAL IJCRR Section: Healthcare Sci. Journal Impact Factor 4.016 Research Article BACTERIOLOGICAL PROFILE AND ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF ISOLATES OF NEONATAL SEPTICEMIA IN A TERTIARY CARE HOSPITAL

More information

ETX0282, a Novel Oral Agent Against Multidrug-Resistant Enterobacteriaceae

ETX0282, a Novel Oral Agent Against Multidrug-Resistant Enterobacteriaceae ETX0282, a Novel Oral Agent Against Multidrug-Resistant Enterobacteriaceae Thomas Durand-Réville 02 June 2017 - ASM Microbe 2017 (Session #113) Disclosures Thomas Durand-Réville: Full-time Employee; Self;

More information

Key Words: Extended spectrum beta lactamase, DDST, PCDDT, E-test ESBL, Prevalence

Key Words: Extended spectrum beta lactamase, DDST, PCDDT, E-test ESBL, Prevalence Original Article Prevalence of Extended Spectrum Beta Lactamase (ESBL) Producers among Gram Negative Bacilli from Various Clinical Isolates in a Tertiary Care Hospital at Jhalawar, Rajasthan, India ID:

More information

Comparison of Antibiotic Resistance and Sensitivity with Reference to Ages of Elders

Comparison of Antibiotic Resistance and Sensitivity with Reference to Ages of Elders Daffodil International University Institutional Repository DIU Journal of Science and Technology Volume 10, Issue 1-2, July 2015 2016-06-16 Comparison of Antibiotic Resistance and Sensitivity with Reference

More information

Clinico-Microbiological Profile of Urinary Tract Infection in Tertiary Care Hospital in Ahmedabad, Gujarat, India

Clinico-Microbiological Profile of Urinary Tract Infection in Tertiary Care Hospital in Ahmedabad, Gujarat, India ISSN: 2319-7706 Volume 4 Number 9 (2015) pp. 288-295 http://www.ijcmas.com Original Research Article Clinico-Microbiological Profile of Urinary Tract Infection in Tertiary Care Hospital in Ahmedabad, Gujarat,

More information

Sepsis is the most common cause of death in

Sepsis is the most common cause of death in ADDRESSING ANTIMICROBIAL RESISTANCE IN THE INTENSIVE CARE UNIT * John P. Quinn, MD ABSTRACT Two of the more common strategies for optimizing antimicrobial therapy in the intensive care unit (ICU) are antibiotic

More information

JMSCR Vol 06 Issue 09 Page September 2018

JMSCR Vol 06 Issue 09 Page September 2018 www.jmscr.igmpublication.org Impact Factor (SJIF): 6.379 Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v6i9.02 Original Clinical Research Prevalence

More information

Breaking the Ring. β-lactamases and the Great Arms Race. Bryce M Kayhart, PharmD, BCPS PGY2 Pharmacotherapy Resident Mayo Clinic - Rochester

Breaking the Ring. β-lactamases and the Great Arms Race. Bryce M Kayhart, PharmD, BCPS PGY2 Pharmacotherapy Resident Mayo Clinic - Rochester Breaking the Ring β-lactamases and the Great Arms Race Bryce M Kayhart, PharmD, BCPS PGY2 Pharmacotherapy Resident Mayo Clinic - Rochester 2015 MFMER slide-1 Disclosures I have no relevant financial relationships

More information

Aerobic Bacterial Profile and Antimicrobial Susceptibility Pattern of Pus Isolates in a Tertiary Care Hospital in Hadoti Region

Aerobic Bacterial Profile and Antimicrobial Susceptibility Pattern of Pus Isolates in a Tertiary Care Hospital in Hadoti Region International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 5 (2017) pp. 2866-2873 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.605.326

More information

Key words: Campylobacter, diarrhea, MIC, drug resistance, erythromycin

Key words: Campylobacter, diarrhea, MIC, drug resistance, erythromycin Key words: Campylobacter, diarrhea, MIC, drug resistance, erythromycin Table 1 Detection rate of Campylobacter from stool samples taken from sporadic diarrheic patients Table 2 Detection rates of Campylobacter

More information

Beta-lactamases in P. aeruginosa: A threat to clinical therapeutics.

Beta-lactamases in P. aeruginosa: A threat to clinical therapeutics. Curr Pediatr Res 2016; 20 (1&2): 253-257 ISSN 0971-9032 www.currentpediatrics.com Beta-lactamases in P. : A threat to clinical therapeutics. Supriya Tankhiwale Government Medical College Nagpur, Department

More information

Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran

Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran Letter to the Editor Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran Mohammad Rahbar, PhD; Massoud Hajia, PhD

More information

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria

More information

Extended-Spectrum Beta-Lactamase-Producing E. Coli and Klebsiella Pneumoniae in Children at University Pediatric Clinic in Skopje

Extended-Spectrum Beta-Lactamase-Producing E. Coli and Klebsiella Pneumoniae in Children at University Pediatric Clinic in Skopje Maced J Med Sci electronic publication ahead of print, published on Fabruary Kaftandzhieva 16, 2009 et as al. doi:10.3889/mjms.1857-5773.2009.0030 Beta-Lactamase-Producing E. Coli and Klebsiella Pneumoniae

More information

2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time)

2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time) Key words I μ μ μ μ μ μ μ μ μ μ μ μ μ μ II Fig. 1. Microdilution plate. The dilution step of the antimicrobial agent is prepared in the -well microplate. Serial twofold dilution were prepared according

More information

Do clinical microbiology laboratory data distort the picture of antibiotic resistance in humans and domestic animals?

Do clinical microbiology laboratory data distort the picture of antibiotic resistance in humans and domestic animals? Do clinical microbiology laboratory data distort the picture of antibiotic resistance in humans and domestic animals? Scott Weissman, MD 2 June 2018 scott.weissman@seattlechildrens.org Disclosures I have

More information